Jan 09, 2024
1:20
For every 20 shares held, investors received 1. The price per share adjusted from $0.36 to $0.02.
The split itself did not change the total investment value.
Titan Pharmaceuticals, Inc. (TTNP) trades on the NASDAQ Capital Market in the Biotechnology industry.
Titan Pharmaceuticals, Inc. company overviewThe latest split shown was on January 9, 2024. It was a 1-for-20 reverse split, so shareholders received 1 share for every 20 they held.
This history records 4 reverse splits between September 29, 2015 and January 9, 2024.
Already premium? Sign in